Zum Hauptinhalt springen
RestrictedBinding ruleSAOriginal is EnglishImport aus amtlicher Quelle geprüft

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6

Listed by the Saudi Food and Drug Authority as restricted in cosmetic products; open the cited detail for the current conditions.

Regulatorische Entscheidung und vollständige Bedingungen

Status
Restricted
Rechtsrolle
Binding rule
Regulatorische Zusammenfassung
Listed by the Saudi Food and Drug Authority as restricted in cosmetic products; open the cited detail for the current conditions.
Bedingungen und Beschränkungen
If this row does not reproduce conditions, open the cited official detail because omission does not mean unrestricted use. Öffnen Sie die zitierte Quelle und wenden Sie die unten genannten marktweiten Anforderungen an.

Stoffidentität

Name in der amtlichen Quelle
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
CAS
11103-57-4; 68-26-8; 127-47-9; 79-81-2
EC
204-844-2
Identitätszuordnung
cas_number
Verknüpfter Inhaltsstoff
RETINYL ACETATE

Verknüpfte CosIng-Identitätsdaten

Namen und Aliase

RETINYL ACETATE

CosIng-Beschreibung: Retinyl acetate

Erfasste kosmetische Funktion: SKIN CONDITIONING, SKIN CONDITIONING - MISCELLANEOUS

Funktionsseiten:SKIN CONDITIONING, SKIN CONDITIONING - MISCELLANEOUS

Das vollständige Inhaltsstoffprofil ansehen

Marktübergreifende Übersicht zu dieser Identität

Exakte verknüpfte Einträge, die derzeit auf dieser Website vorhanden sind. Ein fehlender Markt bedeutet, dass kein exakter Treffer importiert wurde, nicht dass der Stoff verwendet werden darf.

3 Marktdatensätze
Chemische 2D-Struktur aus PubChem für CAS 11103-57-4
CAS 11103-57-4CAS 68-26-8PubChem CID 445354

Verifizierte Chemie für CAS 11103-57-4

Retinol

All-trans-retinol is a retinol in which all four exocyclic double bonds have E- (trans-) geometry. It has a role as a mouse metabolite, a plant metabolite and a human metabolite. It is a vitamin A and a retinol. — ChEBI

IUPAC-Name
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
Summenformel
C20H30O
Molekulargewicht
286.5 g/mol
Exakte Masse
286.229665576 Da
Monoisotopische Masse
286.229665576 Da
XLogP3
5,7
Topologische polare Oberfläche
20,2 Ų
Molekulare Komplexität
496,0
Formale Ladung
0
Wasserstoffbrücken-Donoren
1
Wasserstoffbrücken-Akzeptoren
1
Drehbare Bindungen
5
Schweratome
21
Kovalente Einheiten
1

An PubChem gemeldete Namen und Synonyme

all-trans-Retinol68-26-8Agoncaltrans-retinolVeroftalBentavit AHomagenets AoralSehkraft A
16 weitere gemeldete Namen
Testavol Sall-trans-Vitamin AAll-trans retinolSuper AAxerophtholumWachstumsvitaminVitaminum AVitamine ARetinoloRetinolumRetinol, all trans-(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-olRo-a-vitAntixerophthalmisches Vitamin(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-olG2SH0XKK91
Kennungen in externen Datenbanken
Erweiterte Strukturstatistik
Definierte Atom-Stereozentren
0
Nicht definierte Atom-Stereozentren
0
Definierte Bindungs-Stereozentren
4
Nicht definierte Bindungs-Stereozentren
0
3D-Pharmakophormerkmale
6
3D-Ringe
1
3D-Hydrophobe
3
3D-Akzeptormerkmale
1
3D-Donormerkmale
1
3D-Anionenzentren
0
3D-Kationenzentren
0
3D-Konformere
10
Effektive 3D-Rotoren
5,8
Maschinenlesbare Strukturkennungen
SMILES
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C
InChI
InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+
InChIKey
FPIPGXGPPPQFEQ-OVSJKPMPSA-N

Belege aus weiteren wissenschaftlichen Datenbanken

NIH PubChem PUG-View
Exakter Kennungstreffer445354

Attributed physical-property, hazard, environmental and use annotations.

  • Refractive Index: Index of refraction: 1.6410 at 20 °C/D (calculated form refractive indexes of 20-70% solutions in mineral oil); max absorption: 324-325 nm (E=1,835, 1%, 1 cm) Quelle: Hazardous Substances Data Bank (HSDB)
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not availabl Quelle: CAMEO Chemicals
  • Note: This chemical does not meet GHS hazard criteria for 0.3% (1 of 311) of reports. Quelle: European Chemicals Agency (ECHA)
  • Signal: Danger Quelle: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (15.8%): Harmful if swallowed [Warning Acute toxicity, oral]; H317 (74.9%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (75.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H360 (88.1%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H413 (74.9%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P318, P321, P330, P333+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 311 reports by companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 311 reports by companies.; There are 13 notifications provided by 310 of 311 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
  • Note: This chemical does not meet GHS hazard criteria for 1% (1 of 105) of reports. Quelle: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H317 (99%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (99%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H360D (99%): May damage the unborn child [Danger Reproductive toxicity] Quelle: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P261, P264+P265, P272, P280, P302+P352, P305+P351+P338, P318, P321, P333+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 105 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 105 reports by companies.; There is 1 notification provided by 104 of 105 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org Quelle: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: Signs and Symptoms of Overdose; Vitamin A toxicity may present with various clinical symptoms, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often include mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum retinol levels. Although the diagnosis is primarily clinical, laboratory tests such as serum retinol or retinyl ester levels can assist in confirming the diagnosis. A thorough dietary history is essential to identify excessive vitamin A intake.; Management of Overdose; Symptoms of toxicity may resolve within several weeks after discontinuing vitamin A and initiating supportive therapy. Patients with increased intracranial pressure may require lumbar punctures or medications such as mannitol and diuretics for management. Patients with hypercalcemia may need intravenous fluids and additional treatments, such as calcitonin and corticosteroids. Vitamin A toxicity can present with a range of clinical features, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often show mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum Quelle: StatPearls
  • Toxicity Summary: Vision:Vitamin A (all-trans retinol) is converted in the retina to the 11-cis-isomer of retinaldehyde or 11-cis-retinal. 11-cis-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-cis-retinal, while attached to opsin in rhodopsin is isomerized to all-trans-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-trans-retinal is then released from opsin and reduced to all-trans-retinol. All-trans-retinol is isomerized to 11-cis-retinol in the dark, and then oxidized to 11-cis-retinal. 11-cis-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-cis retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitami Quelle: Toxin and Toxin Target Database (T3DB)

Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen

Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.

Weitere Quellenabdeckung und Trefferstatus
QuelleErgebnisGeprüft
NIH PubChem PUG-ViewExakter Treffer2026-08-31

Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.

Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.

Chemische 2D-Struktur aus PubChem für CAS 127-47-9
CAS 127-47-9PubChem CID 638034

Verifizierte Chemie für CAS 127-47-9

Retinol, acetate

Retinyl acetate is an acetate ester. It is functionally related to an all-trans-retinol. — ChEBI

IUPAC-Name
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate
Summenformel
C22H32O2
Molekulargewicht
328.5 g/mol
Exakte Masse
328.240230259 Da
Monoisotopische Masse
328.240230259 Da
XLogP3
6,3
Topologische polare Oberfläche
26,3 Ų
Molekulare Komplexität
595,0
Formale Ladung
0
Wasserstoffbrücken-Donoren
0
Wasserstoffbrücken-Akzeptoren
2
Drehbare Bindungen
7
Schweratome
24
Kovalente Einheiten
1

An PubChem gemeldete Namen und Synonyme

RETINYL ACETATEVitamin A acetateRetinol acetateVitamin A1 acetateall-trans-Retinol acetateCrystaletsVitamin A alcohol acetateDavitan A 650
16 weitere gemeldete Namen
all-trans-Vitamin A acetateRetinol, acetate, all-trans-(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetateall-trans-RetinylacetateAcetic acid, retinyl ester3LE3D9D6OYVitamin A, acetateVitamin A acetate (tritiated)O(15)-acetylretinolORISTAR RANSC-122045NSC-122760RO-1-5275CHEBI:32095VITAMIN A ACETATE 1.5 M.I.U./G((2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl) acetate
Kennungen in externen Datenbanken
Erweiterte Strukturstatistik
Definierte Atom-Stereozentren
0
Nicht definierte Atom-Stereozentren
0
Definierte Bindungs-Stereozentren
4
Nicht definierte Bindungs-Stereozentren
0
3D-Pharmakophormerkmale
5
3D-Ringe
1
3D-Hydrophobe
3
3D-Akzeptormerkmale
1
3D-Donormerkmale
0
3D-Anionenzentren
0
3D-Kationenzentren
0
3D-Konformere
10
Effektive 3D-Rotoren
7,8
Maschinenlesbare Strukturkennungen
SMILES
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C
InChI
InChI=1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9+,18-14+
InChIKey
QGNJRVVDBSJHIZ-QHLGVNSISA-N

Belege aus weiteren wissenschaftlichen Datenbanken

NIH PubChem PUG-View
Exakter Kennungstreffer638034

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 0.3% (1 of 374) of reports. Quelle: European Chemicals Agency (ECHA)
  • Signal: Danger Quelle: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (83.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H360 (59.4%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H361 (39.6%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H413 (64.4%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P264, P273, P280, P302+P352, P318, P321, P332+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 374 reports by companies from 22 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 374 reports by companies.; There are 21 notifications provided by 373 of 374 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)

Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen

Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.

Weitere Quellenabdeckung und Trefferstatus
QuelleErgebnisGeprüft
NIH PubChem PUG-ViewExakter Treffer2026-08-31

Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.

Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.

Chemische 2D-Struktur aus PubChem für CAS 79-81-2
CAS 79-81-2PubChem CID 5280531

Verifizierte Chemie für CAS 79-81-2

Retinol Palmitate

All-trans-retinyl palmitate is an all-trans-retinyl ester obtained by formal condensation of the carboxy group of palmitic (hexadecanoic acid) with the hydroxy group of all-trans-retinol. It is used in cosmetic products to treat various skin disorders such as acne, skin aging, wrinkles, dark spots, and also protect against psoriasis. It has a role as an antioxidant, a human xenobiotic metabolite and an Escherichia coli metabolite. It is a retinyl palmitate and an all-trans-retinyl ester. It is functionally related to an all-trans-retinol. — ChEBI

IUPAC-Name
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
Summenformel
C36H60O2
Molekulargewicht
524.9 g/mol
Exakte Masse
524.45933115 Da
Monoisotopische Masse
524.45933115 Da
XLogP3
13,6
Topologische polare Oberfläche
26,3 Ų
Molekulare Komplexität
803,0
Formale Ladung
0
Wasserstoffbrücken-Donoren
0
Wasserstoffbrücken-Akzeptoren
2
Drehbare Bindungen
21
Schweratome
38
Kovalente Einheiten
1

An PubChem gemeldete Namen und Synonyme

retinyl palmitateVITAMIN A PALMITATERetinol, hexadecanoateall-trans-Retinyl palmitateArovitOptovit-ARetinyl hexadecanoateVitamin A Solubilized
16 weitere gemeldete Namen
1D1K0N0VVCNSC-758478Retinol, palmitate, all-transAll-(e)-retinol palmitateCHEBI:17616Vitamin a palmitate (solubilized)Retinol Hexadecanoate((2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl) hexadecanoate(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl palmitatepalmitate-1-14cRetinol-15-3HRefChem:56213Retinyl-10,11-14C2CHEBI:15040201-228-5Afaxin
Kennungen in externen Datenbanken
Erweiterte Strukturstatistik
Definierte Atom-Stereozentren
0
Nicht definierte Atom-Stereozentren
0
Definierte Bindungs-Stereozentren
4
Nicht definierte Bindungs-Stereozentren
0
3D-Konformere
0
Maschinenlesbare Strukturkennungen
SMILES
CCCCCCCCCCCCCCCC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C
InChI
InChI=1S/C36H60O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-25-35(37)38-30-28-32(3)23-20-22-31(2)26-27-34-33(4)24-21-29-36(34,5)6/h20,22-23,26-28H,7-19,21,24-25,29-30H2,1-6H3/b23-20+,27-26+,31-22+,32-28+
InChIKey
VYGQUTWHTHXGQB-FFHKNEKCSA-N

Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.

Amtliche Quelle und Herkunft

Registrierte Quelle
Saudi SFDA prohibited and restricted ingredient lists
Quellenverweis
SFDA restricted list, page 36, row 9
Eintrags-ID der Quelle
restricted-35-9
Quellenversion
live-snapshot-2026-08-30
Quellsprache
English
Übersetzungsstatus
Original is English
Stand geprüft
2026-08-30 05:18 UTC
Validierungsmethode
complete SFDA paginated HTML snapshot; strict page/row counts
SHA-256
ceb6cc636e6b1f4b3013f88ce0297217b49d6194342c6ece5c03b1e04256d71a

Hinweise zum registrierten Datensatz

Datensatzabdeckung
Prohibited and restricted substances with CAS, EC and conditions
Hinweis zur Behörde
Official SFDA dated lists; version and hash each release

Wie dieser Eintrag in den Marktdatensatz passt

2090
aktuelle Einträge für Saudi Arabia
364
Einträge mit dem Status Restricted
2090
Einträge aus dieser Quellenversion
1991
Markteinträge mit CAS-Identität

Statusverteilung

Bedingungstext ist bei 0 von 2090 aktuellen Einträgen vorhanden. Ein leeres Bedingungsfeld wird entsprechend der oben genannten Eintragsart interpretiert; es wird niemals in die Aussage einer uneingeschränkten Verwendung umgedeutet.

Saudi Arabia Marktkontext

Complete official list index

Abdeckungsversion: SFDA live prohibited/restricted lists, snapshot 30 August 2026

Every page and entry in the public SFDA prohibited and restricted ingredient indexes; restricted detail pages remain the source for conditions.

Verifizierungs-Checkliste

  1. Search names and CAS across both SFDA lists.
  2. Open the cited restricted-entry detail and apply every condition.
  3. Check current SFDA/GSO technical regulations and updates.
  4. Complete eCosma notification, label and responsible-party requirements.

Amtliche Marktquellen

Verifizierungsablauf und Vollständigkeit des Eintrags

Bevor Sie dieses Ergebnis für eine Compliance-Entscheidung verwenden

  1. Bestätigen Sie, dass „(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate“ und jede CAS-/EC-Kennung sich auf das Material in Ihrer Lieferantenspezifikation beziehen.
  2. Search names and CAS across both SFDA lists.
  3. Open the cited restricted-entry detail and apply every condition.
  4. Check current SFDA/GSO technical regulations and updates.
  5. Complete eCosma notification, label and responsible-party requirements.
  6. Dokumentieren Sie die Quellenversion und prüfen Sie die Behörde vor Herstellung, Notifizierung oder Inverkehrbringen erneut.

In diesem Eintrag verfügbare Felder

  • Amtlicher StoffnameVerfügbar
  • CASVerfügbar
  • ECVerfügbar
  • Gesonderter BedingungstextIn der Quellzeile nicht vorhanden
  • Datum des InkrafttretensNicht angegeben
  • Snapshot-Hash und MethodeVerfügbar

Fragen, die diese Seite beantwortet

This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record. Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.

If this row does not reproduce conditions, open the cited official detail because omission does not mean unrestricted use. No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.

Der Eintrag zitiert SFDA restricted list, page 36, row 9, Quellenversion live-snapshot-2026-08-30. Die amtliche Quelle öffnen.

Nein. CAS hilft bei der Klärung der Identität, aber Rechtsordnungen können denselben Stoff unterschiedlich einstufen und unterschiedliche Produktbereiche, Grenzwerte, Warnhinweise und Übergangsfristen anwenden.

Dauerhafte Zitierweise

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate. SFDA restricted list, page 36, row 9. Saudi Arabia. Source version live-snapshot-2026-08-30. CosIng Checker regulatory record: https://cosingchecker.com/de/regulations/sa/records/11684/

Zitieren Sie die Aufsichtsbehörde als rechtliche Autorität. Diese Seite ist ein strukturierter Belegindex und eine Verifizierungshilfe, kein Ersatz für den amtlichen Text oder eine fachkundige rechtliche Bewertung.

Auslegung und Grenzen für Saudi Arabia

This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.

Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.

Wie die Rechtsrolle auszulegen ist

The cited row forms part of a binding rule or legally incorporated list for this market.

Belege auf dieser Seite

  • Erfasstes Ergebnis: Restricted
  • Rechtsrolle: Binding rule
  • Quellenversion: live-snapshot-2026-08-30

Was es nicht beweist

No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.

Weitere maßgebliche Stoffrecherche

Keine dieser Quellen hebt die oben genannte Marktentscheidung auf.

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

Diese Identität bei der Quelle recherchieren

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

Diese Identität bei der Quelle recherchieren

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

Diese Identität bei der Quelle recherchieren

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

Diese Identität bei der Quelle recherchieren

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

Diese Identität bei der Quelle recherchieren

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

Diese Identität bei der Quelle recherchieren

US EPA CompTox CTX APIs

Für den Import ist ein API-Schlüssel erforderlich

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

Diese Identität bei der Quelle recherchieren